72606-030-01 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
72606-030-02 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
72606-030-03 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
72606-030-04 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
72606-030-05 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
72606-030-06 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
72606-030-07 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
72606-030-08 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
72606-030-09 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
1 SYRINGE in 1 CARTON (72606-030-09) / .4 mL in 1 SYRINGE |
72606-030-10 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
2 SYRINGE in 1 CARTON (72606-030-10) / .4 mL in 1 SYRINGE |
72606-030-11 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
4 SYRINGE in 1 CARTON (72606-030-11) / .4 mL in 1 SYRINGE |
72606-030-12 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230523 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
6 SYRINGE in 1 CARTON (72606-030-12) / .4 mL in 1 SYRINGE |
72606-030-13 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230921 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
4 SYRINGE in 1 CARTON (72606-030-13) / .4 mL in 1 SYRINGE |
72606-030-14 |
72606-030 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
INJECTION |
SUBCUTANEOUS |
20230921 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
40 mg/.4mL |
6 SYRINGE in 1 CARTON (72606-030-14) / .4 mL in 1 SYRINGE |
72606-039-01 |
72606-039 |
HUMAN PRESCRIPTION DRUG |
Yuflyma |
adalimumab |
KIT |
|
20230929 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
|
|
2 KIT in 1 CARTON (72606-039-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE |
72606-040-01 |
72606-040 |
HUMAN PRESCRIPTION DRUG |
Adalimumab |
adalimumab-aaty |
INJECTION |
SUBCUTANEOUS |
20231130 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
80 mg/.8mL |
1 SYRINGE, GLASS in 1 CARTON (72606-040-01) / .8 mL in 1 SYRINGE, GLASS |
72606-040-02 |
72606-040 |
HUMAN PRESCRIPTION DRUG |
Adalimumab |
adalimumab-aaty |
INJECTION |
SUBCUTANEOUS |
20231130 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
80 mg/.8mL |
1 SYRINGE, GLASS in 1 CARTON (72606-040-02) / .8 mL in 1 SYRINGE, GLASS |
72606-040-03 |
72606-040 |
HUMAN PRESCRIPTION DRUG |
Adalimumab |
adalimumab-aaty |
INJECTION |
SUBCUTANEOUS |
20231130 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
80 mg/.8mL |
2 SYRINGE, GLASS in 1 CARTON (72606-040-03) / .8 mL in 1 SYRINGE, GLASS |
72606-040-04 |
72606-040 |
HUMAN PRESCRIPTION DRUG |
Adalimumab |
adalimumab-aaty |
INJECTION |
SUBCUTANEOUS |
20231130 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
80 mg/.8mL |
1 SYRINGE, GLASS in 1 CARTON (72606-040-04) / .8 mL in 1 SYRINGE, GLASS |
72606-040-05 |
72606-040 |
HUMAN PRESCRIPTION DRUG |
Adalimumab |
adalimumab-aaty |
INJECTION |
SUBCUTANEOUS |
20231130 |
N/A |
BLA |
BLA761219 |
CELLTRION USA, Inc. |
ADALIMUMAB |
80 mg/.8mL |
2 SYRINGE, GLASS in 1 CARTON (72606-040-05) / .8 mL in 1 SYRINGE, GLASS |